
### [NCIT:C7402](http://purl.obolibrary.org/obo/NCIT_C7402)
**Label:** Hairy Cell Leukemia

**Subclasses:** [NCIT:C8030](http://purl.obolibrary.org/obo/NCIT_C8030) (Refractory Hairy Cell Leukemia), [NCIT:C8029](http://purl.obolibrary.org/obo/NCIT_C8029) (Progressive Hairy Cell Leukemia Initial Treatment), [NCIT:C7301](http://purl.obolibrary.org/obo/NCIT_C7301) (Splenic Manifestation of Hairy Cell Leukemia), 

**Class expressions from DL-Learner:**

- Thing 54.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 36.92%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40128](http://purl.obolibrary.org/obo/NCIT_C40128) (Fallopian Tube Leiomyosarcoma))) 36.92%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40127](http://purl.obolibrary.org/obo/NCIT_C40127) (Fallopian Tube Leiomyoma))) 36.92%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40125](http://purl.obolibrary.org/obo/NCIT_C40125) (Fallopian Tube Adenosarcoma))) 36.92%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40124](http://purl.obolibrary.org/obo/NCIT_C40124) (Fallopian Tube Carcinosarcoma))) 36.92%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40122](http://purl.obolibrary.org/obo/NCIT_C40122) (Pelvic Pain))) 36.92%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40116](http://purl.obolibrary.org/obo/NCIT_C40116) (Fallopian Tube Metaplastic Papillary Tumor))) 36.92%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40114](http://purl.obolibrary.org/obo/NCIT_C40114) (Fallopian Tube Serous Cystadenofibroma))) 36.92%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40112](http://purl.obolibrary.org/obo/NCIT_C40112) (Fallopian Tube Papilloma))) 36.92%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40110](http://purl.obolibrary.org/obo/NCIT_C40110) (Borderline Fallopian Tube Endometrioid Tumor))) 36.92%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40108](http://purl.obolibrary.org/obo/NCIT_C40108) (Borderline Fallopian Tube Mucinous Tumor))) 36.92%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40107](http://purl.obolibrary.org/obo/NCIT_C40107) (Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor))) 36.92%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40104](http://purl.obolibrary.org/obo/NCIT_C40104) (Fallopian Tube Transitional Cell Carcinoma))) 36.92%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40103](http://purl.obolibrary.org/obo/NCIT_C40103) (Fallopian Tube Mucinous Adenocarcinoma))) 36.92%


